In Vivo cardiac biomechanical model parameter estimation from ultrafast shear wave elastography
Biomechanics and Modeling in Mechanobiology · 2026-12 · 25 (6)
DOI: 10.1007/s10237-026-02142-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomechanics and Modeling in Mechanobiology, online erschienen am 11.11.2026. Verfasst von Camilla Ferrario und 3 weiteren Autor:innen. Beteiligte Einrichtung: Inria, Sophia Antipolis, France. camilla.ferrario@inria.fr. Hauptthemen laut MEDLINE: Elasticity Imaging Techniques, Heart, Models, Cardiovascular. Die Arbeit nennt 30 Literaturangaben. Gefördert von: European Research Council, Agence Nationale de la Recherche, France 2030 / European Union.
Abstract (Originalsprache)
Shear wave elastography (SWE) enables non-invasive acquisition of cycle-resolved myocardial stiffness dynamics, but translating the resulting stiffness waveforms into interpretable mechanical parameters remains a challenging inverse problem. In vivo SWE stiffness reflects the combined effects of passive tissue properties, active contraction, and subject-specific loading conditions, making separation of passive and active contributions essential for distinguishing alterations in myocardial material properties from changes in contractile function. We developed a computational framework based on a closed-loop reduced-order electromechanical model to address this problem. Personalisation was formulated as a sequential inverse problem. An effective passive stiffness contribution was first identified from the diastolic portion of the SWE waveform. The active parameters were then estimated from the residual full-cycle stiffness dynamics. The parameter k 0 defines the maximum active stiffness, while k ATP and k SR govern contraction and relaxation rates, respectively. Parameter estimation used a cohort-regularised objective optimized with the covariance matrix adaptation evolution strategy (CMA-ES). The framework was evaluated in 20 healthy paediatric volunteers, achieving a median active-target mean absolute error of 1.19 kPa and a median correlation of 0.995 for the retained subject-specific solutions. Repeated seeded optimisations yielded highly reproducible objective values, while k ATP showed the greatest across-seed variability, indicating lower identifiability than the other active parameters. These results demonstrate the feasibility of converting non-invasive SWE measurements into model-consistent mechanical signatures and provide a basis for physics-informed myocardial phenotyping in clinical cohorts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Inria, Sophia Antipolis, France. camilla.ferrario@inria.fr.
- IHU Liryc, Electrophysiology and Heart Modeling Institute, Pessac, France. camilla.ferrario@inria.fr.
- Bordeaux University Hospital (CHU), Bordeaux, France.
- IHU Liryc, Electrophysiology and Heart Modeling Institute, Pessac, France.
- Inria, Sophia Antipolis, France. maxime.sermesant@inria.fr.
- IHU Liryc, Electrophysiology and Heart Modeling Institute, Pessac, France. maxime.sermesant@inria.fr.
Förderung
- European Research Council
- Agence Nationale de la Recherche
- France 2030 / European Union
Zitieren
APA
Ferrario, C., Venet, M., Villemain, O., & Sermesant, M. (2026). In Vivo cardiac biomechanical model parameter estimation from ultrafast shear wave elastography. Biomechanics and Modeling in Mechanobiology, 25(6). https://doi.org/10.1007/s10237-026-02142-x
Vancouver
Ferrario C, Venet M, Villemain O, Sermesant M. In Vivo cardiac biomechanical model parameter estimation from ultrafast shear wave elastography. Biomechanics and Modeling in Mechanobiology. 2026;25(6). doi:10.1007/s10237-026-02142-x
BibTeX
@article{Ferrario2026,
author = {Ferrario, Camilla and Venet, Maëlys and Villemain, Olivier and Sermesant, Maxime},
title = {In Vivo cardiac biomechanical model parameter estimation from ultrafast shear wave elastography},
journal = {Biomechanics and Modeling in Mechanobiology},
year = {2026},
volume = {25},
number = {6},
doi = {10.1007/s10237-026-02142-x}
}
EUVIMED